We are live on
!
Find out more
Federated Hermes Portfolio holdings
AUM
$69.6B
1-Year Est. Return
42.52%
This Fund
S&P 500
This Quarter
Est. Return
+13.69%
1 Year Est. Return
+42.52%
3 Year Est. Return
+132.48%
5 Year Est. Return
+152.58%
10 Year Est. Return
+652.43%
AUM
$53.1B
AUM Growth
+$6.76B
(+15%)
Cap. Flow
+$2.33B
Cap. Flow
% of AUM
4.39%
Top 10 Holdings %
Top 10 Hldgs %
14.65%
Holding
2,220
New
169
Increased
729
Reduced
1,033
Closed
165
Avg Time Held
21.7
quarters
Top 10 Avg Time Held
6.6
quarters
Top 20 Avg Time Held
9.9
quarters
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zscaler
ZS
|
+$222M |
| 2 |
Palantir
PLTR
|
+$221M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$213M |
| 4 |
FirstEnergy
FE
|
+$189M |
| 5 |
Broadcom
AVGO
|
+$174M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$383M |
| 2 |
Philip Morris
PM
|
+$280M |
| 3 |
Entergy
ETR
|
+$207M |
| 4 |
Paychex
PAYX
|
+$206M |
| 5 |
Gilead Sciences
GILD
|
+$201M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.81% |
| 2 | Healthcare | 14.57% |
| 3 | Financials | 13.43% |
| 4 | Industrials | 10.29% |
| 5 | Consumer Discretionary | 9.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1576
Rivian
RIVN
$19.4B
| $107K | ﹤0.01% |
7,762
+3,659
| +89% | +$49.6K |
2021 Q4
14 quarters
|
|
1577
Eversource Energy
ES
$24.8B
| $106K | ﹤0.01% |
1,671
-10
| -0.6% | -$616 |
2024 Q3
3 quarters
|
|
1578
Coca-Cola Europacific Partners
CCEP
$46.3B
| $103K | ﹤0.01% |
1,109
-38,732
| -97% | -$3.47M |
2022 Q2
12 quarters
|
|
1579
Avery Dennison
AVY
$12.9B
| $102K | ﹤0.01% |
583
-628
| -52% | -$110K |
2013 Q2
48 quarters
|
|
1580
Corpay
CPAY
$26.2B
| $102K | ﹤0.01% |
308
+297
| +2,700% | +$96.9K |
2017 Q4
30 quarters
|
|
1581
PACCAR
PCAR
$56.8B
| $102K | ﹤0.01% |
1,071
-1,236
| -54% | -$114K |
2013 Q2
48 quarters
|
|
1582
Cincinnati Financial
CINF
$25.4B
| $101K | ﹤0.01% |
+680
| New | +$97.4K |
2025 Q2
0 quarters
|
|
1583
Vivmark Residential
VMRK
$47.4B
| $100K | ﹤0.01% |
+1,488
| New | +$102K |
2025 Q2
0 quarters
|
|
1584
Westlake Corp
WLK
$7.91B
| $99.2K | ﹤0.01% |
1,307
-1,862
| -59% | -$152K |
2021 Q2
16 quarters
|
|
1585
Pliant Therapeutics
PLRX
$59.9M
| $99.1K | ﹤0.01% |
85,421
+26,212
| +44% | +$37K |
2024 Q3
3 quarters
|
|
1586
Comstock Resources
CRK
$4.17B
| $98.1K | ﹤0.01% |
+3,546
| New | +$80.7K |
2025 Q2
0 quarters
|
|
1587
The Kraft Heinz Company
KHC
$26.6B
| $97.1K | ﹤0.01% |
3,760
-1,715
| -31% | -$47.6K |
2015 Q3
39 quarters
|
|
1588
Labcorp
LH
$25.4B
| $95.6K | ﹤0.01% |
364
-462
| -56% | -$112K |
2013 Q2
48 quarters
|
|
1589
Aptiv
APTV
$9.19B
| $95K | ﹤0.01% |
1,392
-485
| -26% | -$30K |
2025 Q1
1 quarter
|
|
1590
CMS Energy
CMS
$20.8B
| $91.2K | ﹤0.01% |
1,317
-11
| -0.8% | -$784 |
2013 Q2
48 quarters
|
|
1591
Waters Corp
WAT
$42.2B
| $90.4K | ﹤0.01% |
259
-1,294
| -83% | -$445K |
2024 Q2
4 quarters
|
|
1592
Insperity
NSP
$1.89B
| $89.8K | ﹤0.01% |
1,493
-3,716
| -71% | -$260K |
2015 Q1
41 quarters
|
|
1593
Fox Class B
FOX
$23.6B
| $86.2K | ﹤0.01% |
1,670
+1,090
| +188% | +$53.1K |
2024 Q3
3 quarters
|
|
1594
Keurig Dr Pepper
KDP
$44.4B
| $85.8K | ﹤0.01% |
2,595
+502
| +24% | +$17K |
2022 Q2
12 quarters
|
|
1595
DELISTED
Coterra Energy
CTRA
| $84.3K | ﹤0.01% |
3,321
+85
| +3% | +$2.15K |
2021 Q2
16 quarters
|
|
1596
McCormick & Company Non-Voting
MKC
$12B
| $83.4K | ﹤0.01% |
1,100
-10
| -0.9% | -$749 |
2013 Q2
48 quarters
|
|
1597
Invitation Homes
INVH
$15.7B
| $81.4K | ﹤0.01% |
+2,481
| New | +$83.3K |
2025 Q2
0 quarters
|
|
1598
Southwest Airlines
LUV
$19.9B
| $80.5K | ﹤0.01% |
+2,480
| New | +$74.7K |
2025 Q2
0 quarters
|
|
1599
DELISTED
Dynavax Technologies
DVAX
| $79.4K | ﹤0.01% |
8,000
| – | – |
2013 Q2
48 quarters
|
|
1600
Ross Stores
ROST
$72.1B
| $79.1K | ﹤0.01% |
620
-56,755
| -99% | -$7.88M |
2013 Q2
48 quarters
|
|
Similar funds
Federated Hermes's Q2 2025 Portfolio in Review
As of Q2 2025, Federated Hermes held 2,220 positions worth $53.1B, up 15% from $46.4B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Federated Hermes deployed $2.33B of net new capital in Q2 2025, opening 169 new positions and adding to 729 existing holdings. Its largest new stake was Genuine Parts: 882,160 shares worth $107M.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 20% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Bristol-Myers Squibb, an estimated $383M trimmed.
- Federated Hermes's largest Q2 2025 buy was Genuine Parts: 882,160 shares worth $107M.
- Federated Hermes added most to Zscaler in Q2 2025, an estimated $222M increase.
- Federated Hermes's biggest Q2 2025 reduction was Bristol-Myers Squibb, cutting an estimated $383M.
- Federated Hermes fully exited Regulus Therapeutics in Q2 2025, selling an estimated $39.2M.
- Federated Hermes's ten largest holdings make up 15% of its $53.1B portfolio in Q2 2025.
- Federated Hermes opened 169 new positions and closed 165 in Q2 2025.
- Federated Hermes's portfolio value rose 15% quarter-over-quarter to $53.1B.
Based on Federated Hermes's 13F filing for Q2 2025, filed 13 Aug 2025.